Emtricitabine And Tenofovir Alafenamide + Rifampin Interaction
Majorinteraction on record
Description
Decreases TAF concentration. Coadministration with DESCOVY is not recommended.
Mechanism
P-gp and BCRP induction leading to decreased TAF absorption
Source: NLP:emtricitabine and tenofovir alafenamide